Rekha Kumar MD
Diabetes, Lipid Metabolism, Obesity, Thyroid
Associate Professor of Clinical Medicine Chief Medical Officer, Found Health Inc.
Request Appointment
425 E. 61st St.8-11th FloorNew York, NY 10065
Overview of Dr. Kumar
Dr. Rekha Kumar is an endocrinologist in New York, NY and is affiliated with NewYork-Presbyterian/Weill Cornell. She received her medical degree from New York Medical College and has been in practice 10 years. She specializes in diabetes, lipid metabolism, obesity, and thyroid and is experienced in metabolic syndrome, diabetes mellitus, obesity and obesity-related disorders, polycystic ovarian syndrome, and thyroid disease.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2012- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2007 - 2010
New York Medical CollegeClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2008 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Program Director of Obesity Medicine Fellowship Weill Cornell Medical College
Publications & Presentations
PubMed
- 3 citationsPerceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study.Lee M Kaplan, Kimberly Gudzune, Jamy Ard, Rekha Kumar, Nadia N Ahmad
Obesity. 2025-06-01 - 1 citationsPerspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study.Jamy Ard, Lee M Kaplan, Scott Kahan, Rekha Kumar, Hong Kan
Population Health Management. 2025-06-01 - 1 citationsLong-Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change.Jennifer M Clark, Brooke J Smith, Jessie L Juusola, Rekha B Kumar
Obesity Science & Practice. 2025-02-01
Journal Articles
- Hypothalamic Inflammation: Is There Evidence for Human Obesity?Kumar, R, Aronne, L., Current Obesity Reports, 3/2014
- Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.Bays HE1, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT., Journal of Clinical Lipidology, 7/2013
Press Mentions
GLP-1RA Microdosing Trend Continues Despite “Anecdotal Evidence”October 28th, 2025- Found Health Launches GLP-1 Microdosing Program for Early Metabolic DysfunctionOctober 28th, 2025
- Costco to Sell Ozempic and Wegovy at a Large Discount for People Without InsuranceOctober 3rd, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
